Acorda Therapeutics
$1.709876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (+0.59%) Today
-$0.01 (-0.58%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell ACOR and other stocks, options, ETFs, and crypto commission-free!
About ACOR
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. Read More The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
CEO
Employees
474
Headquarters
Ardsley, New York
Founded
1995
Market Cap
81.65M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.44M
High Today
$1.75
Low Today
$1.62
Open Price
$1.70
Volume
1.32M
52 Week High
$19.24
52 Week Low
$1.49
Collections
Analyst Ratings
14%
of 7 ratings
Buy
14%
Hold
57%
Sell
29%
ACOR Earnings
-$1.06
-$0.24
$0.58
$1.40
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 13, After Hours